D-Pantothenic acid
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
D-Pantothenic acid (vitamin B5) is a water-soluble vitamin and is an essential nutrient to synthesize coenzyme-A, fats, proteins and carbohydrates.
D-Pantothenic acid is a water-soluble vitamin. In rabbits, pentothenate (20 mg/kg) significantly increased aponeurosis strength after surgery and improved the strength of the skin. Also, pentothenate significantly increased the fibroblast content of the scar during the fibroblast proliferation phase [1]. Pantothenic acid deficiency increased occurrence of hypertension due to adrenal regeneration [2]. In rabbits, cerebellar and forebrain slices were able to accumulate and phosphorylate pantothenic acid. However, medium-chain fatty acids, probenecid and ouabain inhibited pantothenic acid accumulation by forebrain slices and inhibited conversion to CoA [3]. In ICR mice, pantothenic acid significantly reduced valproic acid (VPA)-induced exencephaly, which suggested that pantothenic acid inhibited neural tube defects induced by VPA [4].
References:
[1]. Aprahamian M, Dentinger A, Stock-Damgé C, et al. Effects of supplemental pantothenic acid on wound healing: experimental study in rabbit. Am J Clin Nutr, 1985, 41(3): 578-589.
[2]. Schwabedal PE, Pietrzik K, Wittkowski W. Pantothenic acid deficiency as a factor contributing to the development of hypertension. Cardiology, 1985, 72 Suppl 1: 187-189.
[3]. Spector R. Development and characterization of pantothenic acid transport in brain. J Neurochem, 1986, 47(2): 563-568.
[4]. Sato M, Shirota M, Nagao T. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I). Teratology, 1995, 52(3): 143-148.
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 219.23954 |
| Cas No. | 79-83-4 |
| Formula | C9H17NO5 |
| Solubility | ≥11.15mg/mL in DMSO with gentle warming |
| Chemical Name | 3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoic acid |
| SDF | Download SDF |
| Canonical SMILES | CC(C)(CO)C(C(=O)NCCC(=O)O)O |
| Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. |
Quality Control & MSDS
- View current batch:
Chemical structure
